ABIVAX Soci?t? Anonyme - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABVX Nasdaq 2836 www.abivax.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ABIVAX Soci?t? Anonyme

Abivax Announces Results of its May 11, 2026 Annual General Meeting - May 11th, 2026 2:05 pm
ABIVAX (ABVX) Announces $90M Agreement to Repurchase Royalty Certificates - May 6th, 2026 7:16 am
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares - May 5th, 2026 12:00 am
Here is Why Abivax (ABVX) is One of the Best Up and Coming Stocks with Highest Upside Potential - May 1st, 2026 4:11 am
Abivax to Present Data on Obefazimod at Digestive Disease Week® - Apr 22nd, 2026 2:05 pm
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents - Apr 20th, 2026 2:05 pm
Bright Prospects Ahead for Abivax (ABVX) - Apr 17th, 2026 9:19 am
ABIVAX (ABVX) Appoints Michael Nesrallah as Chief Commercial Officer - Apr 12th, 2026 12:46 pm
This Beaten-Down Drug Stock Is Down Over 10% -- Is It Finally a Buy? - Apr 7th, 2026 1:20 pm
Is ABIVAX (ENXTPA:ABVX) Pricing Reflect Its Sharp Multi‑Year Share Price Surge - Apr 5th, 2026 5:09 pm
ABIVAX SA (ABVX) Surged by 58% in Q4 - Apr 2nd, 2026 7:45 am
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies - Apr 1st, 2026 2:05 pm
2 Healthcare Stocks That Could Soar Over the Next 5 Years - Mar 26th, 2026 3:50 pm
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates - Mar 23rd, 2026 2:05 pm
2 Healthcare Stocks to Buy Before They Get Bought Out - Mar 20th, 2026 3:54 am
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally - Mar 16th, 2026 6:20 pm
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally - Mar 16th, 2026 6:13 pm
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know? - Mar 16th, 2026 5:56 pm
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal - Mar 16th, 2026 5:33 pm
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch - Mar 16th, 2026 5:02 pm